Aug 23 (Reuters) - Cell Impact AB (publ) CELLI.ST :
* NET SALES FOR Q2 OF 2024 AMOUNTED TO SEK 23.8 MILLION
(17.2), UP
38 PERCENT YEAR-ON-YEAR
* WE STILL EXPECT TO BE ABLE TO BREAK EVEN ON EBITDA IN 2025
* OVER LONG TERM, WE SEE A POTENTIALLY HIGHER EBITDA MARGIN
COMPARED WITH MEDIUM-TERM PROFITABILITY
* Q2 OPERATING LOSS (EBIT) WAS SEK -19.6 MILLION (-27.2)
Source text for Eikon: ID:nWkr2h42SR
Further company coverage: CELLI.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))